James V. Caruso
2017
In 2017, James V. Caruso earned a total compensation of $994K as President and Chief Executive Officer at Cellectar Biosciences, a 37% increase compared to previous year.
Compensation breakdown
| Bonus | $164,000 |
|---|---|
| Salary | $410,000 |
| Stock Awards | $420,000 |
| Total | $994,000 |
Caruso received $420K in stock awards, accounting for 42% of the total pay in 2017.
Caruso also received $164K in bonus and $410K in salary.
Rankings
In 2017, James V. Caruso's compensation ranked 9,005th out of 14,666 executives tracked by ExecPay. In other words, Caruso earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,005 out of 14,666 | 39th |
Division Manufacturing | 3,443 out of 5,768 | 40th |
Major group Chemicals And Allied Products | 1,177 out of 2,074 | 43rd |
Industry group Drugs | 941 out of 1,730 | 46th |
Industry Pharmaceutical Preparations | 736 out of 1,329 | 45th |
Source: SEC filing on April 23, 2018.
Caruso's colleagues
We found four more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2017.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019